German Devicemaker Gets CE-IVD Mark for Lung Cancer Assay

Epigenomics, a Germany-based molecular diagnostics company, received the CE-IVD mark for its blood-based lung cancer test Epi proLung.

The device includes the company’s proprietary DNA methylation biomarkers.

The European Commission provided funding for the development of the assay, the company said.